| Cure | No cure or death | OR | p‐value |
Sex (male) | 50 (92.6%) | 12 (75.0%) | 0.2 | 0.074 |
Age# yrs | 31.9±6.1 | 31.5±7.2 | | 0.823 |
Drug addiction | 47 (87.0%) | 13 (81.3%) | 0.7 | 0.685 |
CD4 <200 | 31 (57.4%) | 14 (87.5%) | 5.2 | 0.056 |
Presence of other illness | 35 (64.8%) | 11 (68.8%) | 1.2 | 0.993 |
Use of nucleoside analogous | 32 (59.3%) | 4 (25.0%) | 0.2 | 0.034 |
Use of protease inhibitors | 5 (9.3%) | 2 (12.5%) | 1.4 | 0.655 |
Current i.v. drug use¶ | 12 (25.5%) | 6 (46.2%) | 2.5 | 0.181 |
Multidrug resistance+ | 3 (7.3%) | 4 (26.7%) | 4.6 | 0.074 |
Extrapulmonary tuberculosis | 23 (42.6%) | 6 (37.5%) | 0.8 | 0.941 |
Atypical chest radiograph§ | 31 (57.4%) | 14 (87.5%) | 5.2 | 0.056 |
Modified treatment | 7 (13.0%) | 6 (37.5%) | 4.0 | 0.060 |
Complications | 7 (13.0%) | 11 (68.8%) | 14.8 | <0.001 |
Nonadherence | 9 (16.7%) | 14 (87.5%) | 35.0 | <0.001 |